Effect of Helicobacter pylori eradication on oesophageal acid exposure in patients with reflux oesophagitis

Alimentary Pharmacology and Therapeutics

Volumn 16, Issue 3, 2002, Pages 545-552

  Wu, J C Y ^a   Chan, F K L ^a   Wong, S K H ^a   Lee, Y T ^a   Leung, W K ^a   Sung, J J Y ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; OMEPRAZOLE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; ENDOSCOPY; ERADICATION THERAPY; ESOPHAGUS MANOMETRY; ESOPHAGUS PH; FEMALE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; MALE; PH MEASUREMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REFLUX ESOPHAGITIS;

ADULT; AGED; AMOXICILLIN; ANTI-BACTERIAL AGENTS; ANTI-ULCER AGENTS; CLARITHROMYCIN; DRUG THERAPY, COMBINATION; ESOPHAGITIS, PEPTIC; FEMALE; GASTRIC ACID; GASTROESOPHAGEAL REFLUX; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; HYDROGEN-ION CONCENTRATION; MALE; MIDDLE AGED; OMEPRAZOLE; TREATMENT OUTCOME;

EID: 0036192060     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.2002.01189.x     Document Type: Article

References (25)

1. An inverse relation between cagA+ strains of Helicobacter pylori infection and risk of oesophageal and gastric cardia adenocarcinoma
2. Review article: Helicobacter pylori and gastrooesophageal reflux disease - Clinical implications and management
3. CagA-positive strains of Helicobacter pylori may protect against Barrett's esophagus
4. Decreased prevalence of Helicobacter pylori infection in gastroesophageal reflux disease
5. The seroprevalence of cagApositive Helicobacter pylori strains in the spectrum of gastroesophageal reflux disease
6. Helicobacter pylori infection is associated with milder gastro-oesophageal rellux disease
7. Prevalence and distribution of Helicobacter pylori in gastroesophageal reflux disease: A study from the East
8. Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis
9. Helicobacter pylori infection inhibits reflux esophagitis by inducing atrophic gastritis
10. Intragastric acidity as a predictor of the success of Helicobacter pylori eradication: A study in peptic ulcer patients with omeprazole and amoxicillin
11. Effect of curing Helicobacter pylori infection on intragastric pH during treatment with omeprazole
12. Gastric Helicobacter pylori infection accelerates healing of reflux esophagitis during treatment with the proton pump inhibitor pantoprazole
13. Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication
14. Curent European concepts in the management of Helicobacter pylori infection. The maastricht consensus report
15. Heltcobacter pylori and symptomatic relapse of gastro-oesophageal reflux disease: A randomized controlled trial
16. Endoscopic evaluation of gastro-esophageal reflux disease
17. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis. Houston 1994
18. The effect of Helicobacter pylori eradication on gastro-esophageal reflux
19. Does eradication of Helicobacter pylori influence the recurrence of symptoms in patients with symptomatic gastroesophageal reflux disease? A randomized double blind study
20. Reflux related symptoms in patients with normal oesophageal exposure to acid
21. Clinical esophageal pH recording: A technical review for practice guideline development
22. 24-h pH monitoring for gastroesophageal reflux disease: Already standard but not yet gold?
23. Helicobacter pylori infection and chronic gastric acid hyposecretion
24. Eradicating Helicobacter pylori infection lowers gastrin mediated acid secretion by two thirds in patients with duodenal ulcer
25. Mechanisms of gastroesophageal reflux in patients with reflux esophagitis